REVIEW
Published on 21 Aug 2024
An overview of statistical methods for biomarkers relevant to early clinical development of cancer immunotherapies
doi 10.3389/fimmu.2024.1351584
- 893 views
- 1 citation
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Community Series in Biomarkers in the Era of Cancer Immunotherapy: Zooming in from Periphery to Tumor Microenvironment, Volume II
Community Series in Biomarkers in the Era of Cancer Immunotherapy: Zooming in from Periphery to Tumor Microenvironment, Volume II
17k
Total downloads
59k
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
ORIGINAL RESEARCH
Published on 05 Jul 2024
Investigating the complex interplay between fibroblast activation protein α-positive cancer associated fibroblasts and the tumor microenvironment in the context of cancer immunotherapy
doi 10.3389/fimmu.2024.1352632
- 1,593 views
ORIGINAL RESEARCH
Published on 16 Apr 2024
The factor inhibiting HIF regulates T cell differentiation and anti-tumour efficacy
doi 10.3389/fimmu.2024.1293723
- 1,476 views
REVIEW
Published on 21 Mar 2024
Circulating T cells: a promising biomarker of anti-PD-(L)1 therapy
doi 10.3389/fimmu.2024.1371559
- 1,690 views
- 1 citation
ORIGINAL RESEARCH
Published on 15 Mar 2024
Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies
doi 10.3389/fimmu.2024.1352615
- 4,346 views
- 6 citations
REVIEW
Published on 08 Mar 2024
Biomarkers and computational models for predicting efficacy to tumor ICI immunotherapy
doi 10.3389/fimmu.2024.1368749
- 4,345 views
- 5 citations
ORIGINAL RESEARCH
Published on 22 Feb 2024
Tumor beta2-microglobulin and HLA-A expression is increased by immunotherapy and can predict response to CIT in association with other biomarkers
doi 10.3389/fimmu.2024.1285049
- 2,171 views
- 3 citations
REVIEW
Published on 31 Oct 2023
Small molecule inhibitors for cancer immunotherapy and associated biomarkers – the current status
doi 10.3389/fimmu.2023.1297175
- 11,762 views
- 6 citations
ORIGINAL RESEARCH
Published on 19 Sep 2023
Comprehensive immunophenotyping of solid tumor-infiltrating immune cells reveals the expression characteristics of LAG-3 and its ligands
doi 10.3389/fimmu.2023.1151748
- 4,687 views
- 4 citations
ORIGINAL RESEARCH
Published on 03 Jul 2023
Cyto-IL-15 synergizes with the STING agonist ADU-S100 to eliminate prostate tumors and confer durable immunity in mouse models
doi 10.3389/fimmu.2023.1196829
- 2,624 views
- 5 citations
ORIGINAL RESEARCH
Published on 28 Jun 2023
Targeting immunosuppressive Ly6C+ classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance
doi 10.3389/fimmu.2023.1161869
- 3,980 views
- 5 citations
ORIGINAL RESEARCH
Published on 27 Jun 2023
Clinical significance of CD155 expression and correlation with cellular components of tumor microenvironment in gastric adenocarcinoma
doi 10.3389/fimmu.2023.1173524
- 1,907 views
- 3 citations
Published in
Frontiers in Immunology
- Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Oncology
- 3.5 impact factor
- 6.2 citescore
Impact
- 59kTopic views
- 40kArticle views
- 17kArticle downloads